SymBio Pharmaceuticals Limited

TSE:4582.T

233 (JPY) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2023202220212020201920182017201620152014201320122011201020092008
Operating Activities:
Net Income -1,962.8172,106.2791,001.331-4,086.416-4,372.458-2,748.733-3,974.062-2,309.433-2,628.295-1,112.077-1,601.424-1,729.52-2,100.713-638.507-214.07223.277
Depreciation & Amortization 96.00598.09293.95963.83538.08534.69929.56925.64924.24412.6638.1638.568.1676.5194.3414.303
Deferred Income Tax 1,087.9580-26.755483.94380.10750.58937.023190.69351.498-178.498-49.786-8.1060000
Stock Based Compensation 82.497104.731124.27102.378127.144122.944121.205137.01102.89894.73166.53427.1670000
Change In Working Capital 839.341-59.781-1,066.669-228.531-241.718184.369-35.015-12.683189.465-77.801-126.87835.548-37.878-114.4441.59427.732
Accounts Receivables 1,171.82162.594-1,740.521102.85-288.02351.74-66.077-221.494-28.085-272.656148.08114.3280000
Inventory 237.277-82.746559.235-944.442533.824-171.31-89.789-139.695111.559-119.53239.66242.575-207.467000
Accounts Payables -46.633-23.05-595.776544.546-605.187121.718282.5221.99313.870000000
Other Working Capital -523.124-16.579710.39368.515117.668355.67954.774127.01277.90641.731-166.54-7.027169.589000
Other Non Cash Items -337.669-635.0813.906-457.69218.10231.5854.4878.675-11.496-5.19226.0437.76356.367-7.539-3.19999.075
Operating Cash Flow -194.6851,614.241140.042-4,122.483-4,350.738-2,324.547-3,816.793-1,960.089-2,271.686-1,266.174-1,677.348-1,658.588-2,074.057-753.971-211.336154.387
Investing Activities:
Investments In Property Plant And Equipment -232.797-47.558-63.837-148.931-216.511-39.769-57.021-27.912-23.781-108.5960-3.048-12.362-14.157-3.403-7.988
Acquisitions Net 000000000-64.0460-1.19-10.94000
Purchases Of Investments 000000-23.55-15.923-3.497-2,100-3,537.624-600-201.283-200.905-397.9220
Sales Maturities Of Investments 0000003.06501,5002,558.9712,2052001001004000
Other Investing Activites -143.8990.431-7.012-11.3780.04913.589-20.486-15.92412.92228.0840.37-6.3257.229-0.571-2.627-5.075
Investing Cash Flow -376.696-47.127-70.849-160.309-216.462-26.18-77.507-43.8361,489.141314.413-1,332.254-410.563-117.356-115.633-3.952-13.063
Financing Activities:
Debt Repayment 0000000-2,999.36-0.692-0.682-999.318-0.7190000
Common Stock Issued 681.157662.2270.9034,245.2283,772.4984,278.7121,146.042678.018043.833,066.4604,627.56665.162,971.5618
Common Stock Repurchased -0.996-48.002-72.826-33.677-32.453-29.755-14.372-11.658-1.85-9.72-14.1190-16.738-2.328-8.393-2.168
Dividends Paid 0000000000000000
Other Financing Activities -0.00113.760.00110.5393,740.04523.09932.562,991.817-0.782509.591,004.317-0.719-0.0020-0.001-61.8
Financing Cash Flow 680.16627.985-71.9224,222.093,740.0454,272.0561,164.233,658.177-2.632543.74,056.658-0.7194,610.82662.8322,963.106554.032
Other Information:
Effect Of Forex Changes On Cash 125.673213.7114.209-1.501-83.37-47.032-42.195-196.365-45.459205.9987.059-1.084-24.1931.2363.142-46.221
Net Change In Cash 234.4532,422.44811.48-62.204-910.5251,874.296-2,772.2661,457.887-830.637-202.0621,054.115-2,070.9562,395.213-205.5362,750.961649.134
Cash At End Of Period 6,517.0076,282.5543,860.1063,848.6263,910.834,821.3552,947.0595,719.3254,261.4385,092.0755,294.1374,240.0226,310.9783,915.7654,121.3011,370.34